Chemoinformaics analysis of 3-BETA-O-CIS-P-COUMAROYL-MASLINIC-ACID
| Molecular Weight | 618.855 | nRot | 4 |
| Heavy Atom Molecular Weight | 564.423 | nRig | 35 |
| Exact Molecular Weight | 618.392 | nRing | 6 |
| Solubility: LogS | -3.792 | nHRing | 0 |
| Solubility: LogP | 7.196 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 39 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 105.949 |
| nHD | 3 | BPOL | 57.6452 |
| QED | 0.179 |
| Synth | 4.948 |
| Natural Product Likeliness | 2.862 |
| NR-PPAR-gamma | 0.984 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.114 |
| Pgp-sub | 0.001 |
| HIA | 0.04 |
| CACO-2 | -5.333 |
| MDCK | 0.0000178 |
| BBB | 0.261 |
| PPB | 1.0049 |
| VDSS | 0.798 |
| FU | 0.0208 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.354 |
| CYP2c19-inh | 0.052 |
| CYP2c19-sub | 0.807 |
| CYP2c9-inh | 0.107 |
| CYP2c9-sub | 0.97 |
| CYP2d6-inh | 0.076 |
| CYP2d6-sub | 0.416 |
| CYP3a4-inh | 0.149 |
| CYP3a4-sub | 0.327 |
| CL | 2.181 |
| T12 | 0.024 |
| hERG | 0.01 |
| Ames | 0.014 |
| ROA | 0.106 |
| SkinSen | 0.026 |
| Carcinogencity | 0.045 |
| EI | 0.023 |
| Respiratory | 0.937 |
| NR-Aromatase | 0.857 |
| Antiviral | Yes |
| Prediction | 0.86876 |